CA
JAZZ icon

CSM Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

CSM Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Sell
4,568
-401
-8% -$87.8K 0.02% 338
2026
Q1 		$939K Buy
4,969
+306
+7% +$53.5K 0.02% 338
2025
Q4 		$793K Sell
4,663
-1,383
-23% -$212K 0.02% 340
2025
Q3 		$796K Buy
6,046
+947
+19% +$114K 0.02% 346
2025
Q2 		$541K Buy
+5,099
New +$554K 0.02% 333

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

CSM Advisors's JAZZ Position: Q2 2026 in Review

CSM Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 8.1% in Q2 2026, selling an estimated $87.8K and leaving 4,568 shares worth $1.1M. The position accounts for 0.02% of the portfolio, ranked #338.

CSM Advisors first reported a position in JAZZ in Q2 2025 and has held it in 5 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • CSM Advisors held 4,568 shares of Jazz Pharmaceuticals worth $1.1M as of Q2 2026.
  • CSM Advisors sold 401 Jazz Pharmaceuticals shares in Q2 2026, an estimated $87.8K.
  • Jazz Pharmaceuticals made up 0.02% of CSM Advisors's portfolio in Q2 2026, its #338 holding.
  • CSM Advisors first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on CSM Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.